Why is amyloid-β PET requested after performing CSF biomarkers?

statement of authorship
Reimand, Juhan, Groot, Colin, Teunissen, Charlotte E., Windhorst, Albert D., Boellaard, Ronald, Barkhof, Frederike, Nazarenko, Sergei, van der Flier, Wiesje M., van Berckel, Bart N.M., Scheltens, Philip, Ossenkoppele, Rik, Bouwman, Femke
publisher
journal volume number month
vol. 73, 2
year of publication
pages
p. 559-569
ISSN
1387-2877
notes
Bibliogr.: 32 ref
Open Access
Open Access
scientific publication
teaduspublikatsioon
classifier
1.1
category (general)
kvartiil
Q2
language
inglise
Reimand, J., Groot, C., Teunissen, C.E. et al. Why is amyloid-β PET requested after performing CSF biomarkers? // Journal of Alzheimer's disease (2020) vol. 73, 2, p. 559-569. https://doi.org/10.3233/JAD-190836